Logo image
( d)-2- tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: Synthesis and incorporation into the growth hormone secretagogues
Journal article   Peer reviewed

( d)-2- tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: Synthesis and incorporation into the growth hormone secretagogues

Jun Li, Stephanie Y. Chen, Brian J. Murphy, Neil Flynn, Ramakrishna Seethala, Dorothy Slusarchyk, Mujing Yan, Paul Sleph, Hongjian Zhang, William G. Humphreys, …
Bioorganic & medicinal chemistry letters, v 18(14), pp 4072-4074
15 Jul 2008
PMID: 18554903
url
https://doi.org/10.7270/q2dr2wf8View
Open

Abstract

Growth hormone secretagogue
The first enantioselective synthesis of ( d)-2- tert-butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid 3 was achieved. The incorporation of the titled compound into growth hormone secretagogue (GHS) compounds resulted in new analogs 10 and 16, both of which had significantly increased in vitro potency. The compound 10 also showed improved in vivo efficacy as well as pharmacokinetic properties in rat models.

Metrics

4 Record Views
12 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Chemistry, Medicinal
Chemistry, Organic
Logo image